Annovis Bio, Inc. SEC filings ANVS
Annovis Bio, Inc. has 315 filings in SEC EDGAR's recent list, going back to Jan 15, 2010. Its latest annual report, Form 10-K, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 19, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2025 | — |
| EFFECT | Filing | Feb 12, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2024 | — |
| D | Filing | Apr 25, 2023 | — |
| 25 | Filing | Nov 26, 2021 | — |
| CERT | Nyse certification | Nov 17, 2021 | — |
| 8-A12B | Filing | Nov 17, 2021 | — |
| EFFECT | Filing | Feb 11, 2021 | — |
| CORRESP | Letter to the SEC | Feb 9, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2021 | — |
| EFFECT | Filing | Jan 28, 2020 | — |
| CERT | Nyse american certification | Jan 28, 2020 | — |
| 8-A12B | Form 8-a12b | Jan 28, 2020 | — |
| CORRESP | Letter to the SEC | Jan 24, 2020 | — |
| CORRESP | Letter to the SEC | Jan 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 20, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2019 | — |
| CORRESP | Letter to the SEC | Aug 27, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2019 | — |
| CORRESP | Letter to the SEC | Aug 8, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 2, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| DRSLTR | Filing | May 24, 2019 | — |
| DRS/A | Filing | May 24, 2019 | — |
| DRSLTR | Filing | May 15, 2019 | — |
| DRS | Filing | May 15, 2019 | — |
| D | Filing | Mar 15, 2019 | — |
| D | Filing | Dec 22, 2017 | — |
| D | Filing | Oct 26, 2016 | — |
| D/A | Filing | Jun 5, 2015 | — |
| D | Filing | Jan 5, 2015 | — |
| D/A | Filing | Dec 30, 2013 | — |
| D | Filing | Jun 20, 2013 | — |
| D | Filing | Apr 26, 2010 | — |
| D | Filing | Jan 15, 2010 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1477845
- Former names
- QR Pharma, Inc. (until Mar 15, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.